Orthofix International to Participate in the Lazard Capital Markets 9th Annual Healthcare Conference
Orthofix International to Participate in the Lazard Capital Markets 9thAnnual Healthcare Conference
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V., (NAS: OFIX) (the Company) announced today that it will participate in the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14th at 10:00 AM Eastern Time at the Pierre Hotel in New York, NY.
A live audio webcast will be available on the Company's website at www.orthofix.com by clicking on the Investors tab and then clicking the link on the Events & Presentations page.
About Orthofix:
Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Director of Investor Relations and Business Development
markquick@orthofix.com
KEYWORDS: United States North America New York Texas
INDUSTRY KEYWORDS:
The article Orthofix International to Participate in the Lazard Capital Markets 9th Annual Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
